Eva Løbner Lund

Eva Løbner Lund is an Associate Professor and Senior Consultant Neuropathologist at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. She maintains a dual role as a clinical neuropathologist at Copenhagen University Hospital (Region Hovedstaden) where she practices as a Senior Consultant. Her work bridges clinical neuropathology with cutting-edge research in neurodegenerative disorders, focusing particularly on diagnostic methodologies for conditions like Parkinson's disease and Creutzfeldt-Jakob disease.

Dr. Lund's research interests center on neuropathology with special emphasis on neurodegenerative disorders characterized by protein misfolding. She has developed expertise in detecting pathological proteins such as α-synuclein and prions across various biological samples including CSF, skin, and olfactory mucosa. Her work aims to establish standardized diagnostic protocols that can be implemented across clinical settings to improve early detection of neurodegenerative conditions. This research has significant implications for patient stratification and potential therapeutic interventions.

Analysis of Dr. Lund's recent publication record reveals a consistent focus on developing and validating diagnostic assays for neurodegenerative diseases. Her work spans from fundamental research on disease mechanisms to practical clinical applications of diagnostic methods. A notable trend is her participation in international multi-center studies that aim to standardize detection protocols for pathological proteins across different healthcare systems. Her 2025 publications particularly highlight advances in uniform seeding amplification assays for α-synuclein detection across multiple sample types.

Dr. Lund maintains active collaborations with research institutions across Europe and North America, contributing her neuropathology expertise to large-scale studies on neurodegenerative diseases. Her clinical position at Copenhagen University Hospital provides essential real-world context for her research, ensuring that diagnostic developments address actual clinical challenges faced by neuropathologists and neurologists.